Cite
Kowalczyk T, Kisluk J, Pietrowska K, et al. The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133314.
Kowalczyk, T., Kisluk, J., Pietrowska, K., Godzien, J., Kozlowski, M., Reszeć, J., Sierko, E., Naumnik, W., Mróz, R., Moniuszko, M., Kretowski, A., Niklinski, J., & Ciborowski, M. (2021). The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied. Cancers, 13(13), . https://doi.org/10.3390/cancers13133314
Kowalczyk, Tomasz, et al. "The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133314
Kowalczyk T, Kisluk J, Pietrowska K, Godzien J, Kozlowski M, Reszeć J, Sierko E, Naumnik W, Mróz R, Moniuszko M, Kretowski A, Niklinski J, Ciborowski M. The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied. Cancers (Basel). 2021 Jul 01;13(13). doi: 10.3390/cancers13133314. PMID: 34282765; PMCID: PMC8268630.
Copy
Download .nbib